Stereotactic radiosurgery of the rat Dunning R3327-AT1 prostate tumor

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 2, 1996, Pages 385-391

  Henke, Karin ^a   Hartmann, Günther H ^a   Peschke, Peter ^a   Hahn, Eric W ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Animal model; Radiobiology; Stereotactic radiosurgery

Indexed keywords

BROXURIDINE; CYCLINE; DNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; RADIATION DOSE; RADIOSURGERY; RAT; STEREOTAXIC SURGERY; TUMOR VOLUME;

EID: 0030249474     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00266-0     Document Type: Article

References (23)

1. 1. Bravo, R.; Frank, R.; Blundell, P. A.; Macdonald-Bravo, H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature 326:515-517; 1987.
2. 2. Coltreta, M. D.; Gown, A. M. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines. J. Histochem. Cytochem. 39:23; 1991.
3. 3. Deruty, R.; Pelissou-Guyotat, I.; Mottolese, C.; Bascoulergue, Y.; Amat, D. The combined management of cerebral arteriovenous malformations. Experience with 100 cases and review of the literature. Acta Neurochir. Wien. 123:101-112; 1993.
4. 4. Dunning, W. F. Prostatic cancer in the rat. Natl. Cancer Inst. Monogr. 12:351-369; 1963.
5. 5. Goldner, J. A modification of the Masson trichromtechnique for routine laboratory purpose. Am. J. Pathol. 14:237-243; 1938.
6. 6. Gratzner, H. G. Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218:474-475; 1982.
7. 7. Hahn, E. W.; Klein, V.; Wesch, H.; Zuna, I.; Peschke, P. Neutron activation analysis of bromine in tumor cell DNA. In: Hagen, U., ed. Radiation research 1895-1995, vol. 1. Würzburg: University of Würzburg; 1995:185.
8. 8. Hall, E. J.; Brenner, D. J. The radiobiology of radiosurgery: Rationale for different treatment regimes for AVMs and malignancies. Int. J. Radiat. Oncol. Biol. Phys. 25:381-385; 1993.
9. 9. Hartmann, G. H.; Schlegel, W.; Sturm, V.; Kober, B.; Pastyr, O.; Lorenz, W. J. Cerebral radiation surgery using moving field irradiation at a linear accelerator facility. Int. J. Radiat. Oncol. Biol. Phys. 11:1185-1192; 1985.
10. 10. Isaacs, J. T.; Heston, W. D. W.; Weissman, R. M.; Coffey, D. S. Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT1. Cancer Res. 38:4353-4359; 1978.
11. 11. Klein, V.; Peschke, P.; Bader, R.; Hahn, E. W. Morphometric analysis of the distribution of Brd Urd in the Dunning prostate tumor R3327-AT1 after heat and radiation. In: Whitemore, G. F., ed. 42nd Annual Meeting of the Radiation Research Society. Dallas, TX: Radiation Research Society; 1994:127.
12. 12. Kondziolka, D.; Lunsford, L. D.; Maitz, A. H.; Flickinger, J. C. Radiobiology of radiosurgery: Part I. The normal rat brain model. Neurosurgery 31:271-279; 1992.
13. 13. Kurki, P.; Ogata, K.; Tan, E. M. Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J. Immunol. Methods 109:49-59; 1988.
14. 14. Larson, D. A.; Flickinger, J. C. The radiobiology of radio-surgery. Int. J. Radiat. Oncol. Biol. Phys. 25:557-561; 1993.
15. 15. Lo, E. H.; DeLaPaz, R. L.; Frankel, K. A.; Poljak, A.; Phillips, M. H.; Brennan, K. M.; Woodruft, K. H.; Valk, P. E.; Steinberg, G. K.; Fabrikant, J. I. MRI and PET of delayed heavy-ion radiation injury in the rabbit brain. Int. J. Radiat. Oncol. Biol. Phys. 20:689-696; 1991.
16. 16. Lohr, F.; Wenz, F.; Flentje, M.; Peschke, P.; Hahn, E. W. Measurement of the proliferative activity of three different sublines of the Dunning rat prostate tumor R3327. Strahlenther. Onkol. 169:438-445; 1993.
17. 17. Lubaroff, D. M.; Canfield, L.; Feldbush, T. L.; Bonney, W. W. R3327 adenocarcinoma of the Copenhagen rat as model for the study of the immunologic aspects of prostate cancer. J. Natl. Cancer Inst. 58:1677-1681; 1977.
18. 18. Mathews, M. B.; Bernstein, R. M.; Franza, B. R., Jr.; Garrels, J. I. Identity of the proliferating cell nuclear antigen and cyclin. Nature 309:374-376; 1984.
19. 19. Serago, C. F.; Lewin, A. A.; Houdek, P. V.; Gonzales-Arias, S.; Hartmann, G. H.; Abitbol, A. A.; Schwade, J. G. Stereotactic target point verification of an X ray and CT localizer. Int. J. Radiat. Oncol. Biol. Phys. 20:517-523; 1991.
20. 20. Siddon, R. L.; Barth, N. H. Stereotactic localization of intracranial targets. Int. J. Radiat. Oncol. Biol. Phys. 13:1241-1246; 1987.
21. 21. Smetana, K.; Gyorkey, F.; Chan, P.-K.; Tan, E.; Busch, H. Proliferating cell nuclear antigen (PCNA) and human malignant tumor nucleolar antigens (HMTNA) in nucleoli of human hematological malignancies. Blut 46:133-141; 1983.
22. 22. Weissman, R. M.; Coffey, D. S.; Scott, W. W. Cell kinetic studies of prostatic cancer: Adjuvant therapy in animal models. Oncology 34:133-137; 1977.
23. 23. Wurster, K.; Kuhlmann, W. D.; Rapp, W. Immunohistochemical studies on human gastric mucosa. Virchows Arch. A Pathol. Anat. Histol. 378:213-228; 1978.